How does Trendshare evaluate AMPE as a worked example?

This example shows how we apply the Trendshare checklist to AMPE: earnings power, cash generation, valuation, and margin of safety. We look at business quality, free cash flow trends, price to earnings, and whether there is a reasonable margin of safety at the current price of 0.26.

Ampio Pharmaceuticals Stock Price and Value Analysis

Should you buy Ampio Pharmaceuticals stock? (NYSE American:AMPE). Let's see how it does in our automated value investing analysis system.

Hold-time calculator

Estimate how long you need to hold Ampio Pharmaceuticals to reach your target.

Target type Target price Target total return %

Current price

Expected annual return (compound annual growth rate, CAGR)

Margin of safety (%)

Target price (Trendshare FV)

Include dividend yield
N/A

Advantages	Disadvantages	Neutral
This company is solid.	This stock looks overpriced. This company has wild ups and downs. This company is not making money.	This company pays no dividend.

Inside the AMPE Numbers

	AMPE Price (Ampio Pharmaceuticals stock price per share)	$0.26
× PE Ratio Versus Sector The PE ratio measures the reported earnings of a company to its current stock price. While earnings are easy to manipulate on the balance sheet, this ratio gives you a sense of what buyers are willing to pay for the stock—what they believe it will do in the future. Comparing a stock's PE to the average PE of companies in its industry gives you a sense of market sentiment about the stock and how well it fares financially. It's not the only number, nor the most important, but comparing similar companies is valuable. A ratio far above or below that of its peers is significant. Industries are more specific than sectors, so companies within most industries are more similar than are companies within an industry. Be aware that the size and customers of companies are important to their prospects. Close ^[?]	PE Ratio versus Sector	40% higher than other Healthcare stocks
× PE Ratio Versus Industry The PE ratio measures the reported earnings of a company to its current stock price. While earnings are easy to manipulate on the balance sheet, this ratio gives you a sense of what buyers are willing to pay for the stock—what they believe it will do in the future. Comparing a stock's PE to the average PE of companies in its sector gives you a sense of market sentiment about the stock and how well it fares financially. It's not the only number, nor the most important, but comparing similar companies is valuable. A ratio far above or below that of its peers is significant. Be aware that sectors are very broad, with many types of companies in the same sector. Close ^[?]	PE Ratio versus Industry	50% lower than other Biotechnology stocks
× Cash Yield The cash yield of a stock is the ratio of free cash per share—real dollars available after bringing in revenue and paying bills—to the current price of the stock. It's similar to the PE ratio, but it's less prone to manipulation through accounting practices. In general, the less you have to pay to make more money, the better. Close ^[?]	Cash Yield	-16.38%
× Free Cash Flow Jitter The free cash flow jitter of a stock measures how much the company's free cash flow varies from its historical trend, on average. While it's always nice to make more money than you expected, a company with predictable free cash flow is stable and good. A company with wild swings in its free cash flow warrants further research. In general, the lower this number, the better. Close ^[?]	Free Cash Flow Jitter	58%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 12,005,487 shares shorted. With 209,301,775 shares available for purchase and an average trading volume over the past 10 trading days of 269,390, it would take at least 44.565 days for all of the short holders to cover their shorts.

What does this mean to you? At this volume, it'll take more than two trading weeks for shorts to cover. This may indicate a short squeeze play would work! If this stock has good fundamentals and it'll take a while for the short holders to cover, buying now could net you bigger short-term technical gains if and as the price rises.

Is Ampio Pharmaceuticals Stock on Sale?

Based on our analysis, we believe that you should not buy Ampio Pharmaceuticals right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy AMPE Stock?

Does Ampio Pharmaceuticals have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Step 1 — Snapshot
- Price: 0.26
- Market cap: $60M
- EPS: -0.092
Step 2 — Valuation checks
- P/E: 28.57
- FCF yield: -16.4%
- Date checked: Dec 16, 2022
Step 3 — Margin of safety
- Compare price to fair value and safety price.
- Look for durable cash generation and reasonable leverage.
- Decide if it passes your personal checklist.

Illustrative sparkline of recent price-like movements (not an actual price series). The blue line shows a simplified trend; the gray baseline is a notional recent level. This graphic is a visual aid only — use the numeric values in the steps above for decisions.

Ampio Pharmaceuticals Stock Price and Value Analysis

Hold-time calculator

Inside the AMPE Numbers

Is Ampio Pharmaceuticals Stock on Sale?

Should You Buy AMPE Stock?

Step 1 — Snapshot

Step 2 — Valuation checks

Step 3 — Margin of safety